Form 4: Vericel Corp CFO Joseph Mara Reports Stock Transactions
SEC Form 4 Filing
Chief Financial Officer Joseph Mara of Vericel Corp reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- On February 18, 2025, Joseph Mara, the CFO of Vericel Corp, reported transactions involving common stock and restricted stock units (RSUs).
- Mara acquired 4,625 shares of common stock through the vesting of RSUs granted on February 17, 2023, and another 2,754 shares through the vesting of RSUs granted on February 18, 2022.
- Simultaneously, Mara disposed of 1,450 shares and 809 shares to satisfy tax withholding requirements related to the vesting of the RSUs, at a price of $57.28 per share.
- Following these transactions, Mara directly owns 19,700 shares of Vericel Corp common stock and 2,755 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine filing related to executive compensation and does not indicate any significant positive or negative sentiment.
Future Outlook
The remaining RSUs granted on February 17, 2023, will vest in annual installments on February 17, 2026, and February 17, 2027. The remaining RSUs granted on February 18, 2022, will vest on February 18, 2026.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions, which are closely monitored by investors.
Key Dates
| Date | Description |
|---|---|
| February 17, 2023 | Date RSUs were granted to the Reporting Person. |
| February 18, 2022 | Date RSUs were granted to the Reporting Person. |
| February 18, 2025 | Date of the reported transactions (vesting and disposal of shares). |
| February 17, 2026 | Date of next annual installment vesting of RSUs granted on February 17, 2023. |
| February 18, 2026 | Date of vesting of remaining RSUs granted on February 18, 2022. |
| February 17, 2027 | Date of final annual installment vesting of RSUs granted on February 17, 2023. |
| February 20, 2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.